Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Direct-to-consumer advertising: Who’s really to blame?

Peter Ubel, MD
Physician
October 27, 2017
Share
Tweet
Share

There are some sad truths about being an aging male. Your muscle mass usually declines. You start feeling tired more easily. And there’s a good chance either you start losing interest in sex or start experiencing a decline in sexual performance.

Here’s another truth: Your testosterone level probably ain’t what it used to be. Which raises a question: Would testosterone supplementation restore some of your youthful vitality?

That is certainly what manufactures of testosterone treatments wanted people to think when they began purchasing TV time to play ads encouraging men to get their testosterone level checked. But since the early onslaught of these “low T” ads, medical science has taught us that testosterone replacement is often unnecessary. Moreover, unnecessary replacement can potentially lead to heart disease. That makes it likely that those television ads, rather than restoring people’s vitality, shortened their lives.

It’s important to be clear that testosterone supplementation is not always harmful.

  • In people with diseases affecting their ability to produce testosterone, treatment can be very beneficial.
  • But in people with no such diseases who have normal age-related declines in circulating testosterone, there is no solid evidence that treatment makes them healthier or improves their quality of life.
  • And in people with normal age-related testosterone levels, treatment might—might!—increase the odds of heart attack or stroke.

In short, testosterone isn’t the wonder drug some hoped it would be. That’s why testosterone manufacturers voluntarily stopped direct to consumer advertisements in 2014.

By then, for some unsuspecting customers, the damage was already done. According to a study published in JAMA, testosterone testing and treatment rose in areas exposed to relatively large numbers of testosterone television ads. Some areas of the country, for example, had 30 percent more testosterone ads on television than other areas. It was those areas that had increases in testosterone testing and treatment. Here’s a map, showing parts of the country with particularly high exposure to such commercials:

Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013

The researchers found that, in places where there were lots of testosterone TV ads:

  • Testosterone testing increased.
  • Testosterone treatment increased.
  • And some of those treatments occurred even though men didn’t get their testosterone levels checked.

Basically, that means many men received an unnecessary and potentially harmful drug.

Whose fault is this?

Well, I don’t blame the general public. When a television ad asks you to talk to your doctor about whether your testosterone level is causing you to feel sluggish or weak, why wouldn’t you do that?

I don’t blame direct-to-consumer advertising, either. At least, I don’t give it the lion’s share of the blame. Undoubtedly, we should require strong evidence of health benefit before allowing drug manufacturers to advertise their products. And the content of those ads needs to be scrutinized by the FDA.

But ultimately, physicians need to be less eager to prescribe medicines to patients who haven’t been shown to benefit from those treatments.

What should consumers do when their television sets persuade them to get medical tests or treatments? Don’t ask your doctor to prescribe that new wonder drug advertised on TV without also asking her whether she is confident that drug will do more good than harm. Remember: physicians are sometimes influenced by advertising hype, too.

ADVERTISEMENT

Peter Ubel is a physician and behavioral scientist who blogs at his self-titled site, Peter Ubel and can be reached on Twitter @PeterUbel. He is the author of Critical Decisions: How You and Your Doctor Can Make the Right Medical Choices Together. This article originally appeared in Forbes.

Image credit: Shutterstock.com

Prev

Residency and family: How this resident finds balance

October 27, 2017 Kevin 0
…
Next

C. difficile: We are not winning the war against this cunning adversary

October 27, 2017 Kevin 1
…

Tagged as: Endocrinology, Urology

Post navigation

< Previous Post
Residency and family: How this resident finds balance
Next Post >
C. difficile: We are not winning the war against this cunning adversary

ADVERTISEMENT

More by Peter Ubel, MD

  • Clinicians shouldn’t be punished for taking care of needy populations

    Peter Ubel, MD
  • Patients alone cannot combat high health care prices

    Peter Ubel, MD
  • Is the FDA too slow to handle the pandemic?

    Peter Ubel, MD

Related Posts

  • Here’s why direct-to-consumer drug ads need FDA oversight

    Zachariah Tman
  • Drug advertising has helped created victim politics

    Martha Rosenberg
  • A physician’s addiction to social media

    Amanda Xi, MD
  • Who’s really to blame for the obesity epidemic?

    Peter Ubel, MD
  • GOOP and Gwyneth: Blame mainstream media

    Arthur L. Caplan, PhD and Timothy Caulfield, LLM
  • Should the government regulate hearing aids as consumer electronic products?

    Shari A. Hicks, CPhT

More in Physician

  • How just culture can reduce burnout and boost health care staff retention

    Olumuyiwa Bamgbade, MD
  • Why embracing imperfection makes you truly unforgettable

    Osmund Agbo, MD
  • The unseen burden patients carry between appointments

    Ryan Nadelson, MD
  • My journey to loving primary care again

    Jerina Gani, MD, MPH
  • Why doctors striking may be the most ethical choice

    Patrick Hudson, MD
  • How photos shape drug stigma—and what we can do about it

    Jeffrey Hom, MD, MPH, MSHP
  • Most Popular

  • Past Week

    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
    • How AI, animals, and ecosystems reveal a new kind of intelligence

      Fateh Entabi, MD | Tech
    • Why kratom addiction is the next public health crisis

      Muhamad Aly Rifai, MD | Meds
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • How just culture can reduce burnout and boost health care staff retention

      Olumuyiwa Bamgbade, MD | Physician
    • The hidden moral injury behind value-based health care

      Jonathan Bushman, DO | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • How just culture can reduce burnout and boost health care staff retention

      Olumuyiwa Bamgbade, MD | Physician
    • Why embracing imperfection makes you truly unforgettable

      Osmund Agbo, MD | Physician
    • Affordable postpartum hemorrhage solutions every OB/GYN should know

      Frank I. Jackson, DO | Conditions
    • Why kratom addiction is the next public health crisis

      Muhamad Aly Rifai, MD | Meds
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
    • How are prostate exams done and why you shouldn’t avoid them

      Martina Ambardjieva, MD, PhD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 2 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
    • How AI, animals, and ecosystems reveal a new kind of intelligence

      Fateh Entabi, MD | Tech
    • Why kratom addiction is the next public health crisis

      Muhamad Aly Rifai, MD | Meds
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • How just culture can reduce burnout and boost health care staff retention

      Olumuyiwa Bamgbade, MD | Physician
    • The hidden moral injury behind value-based health care

      Jonathan Bushman, DO | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • How just culture can reduce burnout and boost health care staff retention

      Olumuyiwa Bamgbade, MD | Physician
    • Why embracing imperfection makes you truly unforgettable

      Osmund Agbo, MD | Physician
    • Affordable postpartum hemorrhage solutions every OB/GYN should know

      Frank I. Jackson, DO | Conditions
    • Why kratom addiction is the next public health crisis

      Muhamad Aly Rifai, MD | Meds
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
    • How are prostate exams done and why you shouldn’t avoid them

      Martina Ambardjieva, MD, PhD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Direct-to-consumer advertising: Who’s really to blame?
2 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...